Prolongation of cardiac allograft survival in murine recipients treated with a diphtheria toxin- related interleukin-2 fusion protein

Transplantation

Volumn 47, Issue 2, 1989, Pages 327-330

  Kirkman, Robert L ^a,b,c   Bacha, Pat ^a,b,c   Barrett, Leslie V ^a,b,c   Forte, Serene ^a,b,c   Murphy, John R ^a,b,c   Strom, Terry B ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c Seragen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; INTERLEUKIN 2; TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMAL; ANTIBODY FORMATION; DIPHTHERIA TOXIN; GRAFT SURVIVAL; HALF-LIFE; HEART TRANSPLANTATION; INTERLEUKIN-2; KIDNEY; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024538909     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-198902000-00028     Document Type: Article

References (23)

1. Cotner T, Williams JM, Christenson L, Shapiro HJ, Strom TB, Strominger J. Simultaneous flow cytometric analysis of human T-cell activation antigen expression and DNA content. J Exp Med 1983; 157: 461.
2. Waldmann TA. The structure, function, and expression of inter- leukin-2 receptors on normal and malignant lymphocytes. Science 1986; 232: 727.
3. Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice. J Exp Med 1985; 162: 358.
4. Kirkman RL, Barrett LV, Koltun WA, Diamantstein T. Prolongation of murine cardiac allograft survival by the anti-interleukin 2 receptor monoclonal antibody AMT-13. Transplant Proc 1987; 19: 618.
5. Kupiec-Weglinski JW, Diamantstein T, Tilney NL, Strom TB. Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats. Proc Natl Acad Sci USA 1986; 83: 2624.
6. Kupiec-Weglinski JW, Hahn HJ, Kirkman RL, et al. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy. Transplant Proc 1988; 20: 207.
7. Reed MH, Shapiro ME, Strom TB, et al. Prolongation of primate renal allografts with anti-Tac monoclonal antibody. Curr Surg 1988; 45: 28.
8. Soulillou JP, Peyronnet P, LeMauff B, et al. Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin receptor. Lancet 1987; 1: 1339.
9. Tsudo M, Kozak RW, Goldman CK, Waldmann TA. Demonstra tion of a new peptide (non-Tac) that binds IL-2: a potential participant in a multichain IL-2 receptor complex. Proc Natl Acad Sci USA 1986; 83: 9694.
10. Robb R, Rusk CM, Yodoi J, Greene WC. An interleukin-2 binding molecule distinct from the Tac protein: analysis of its role in formation of high affinity receptors. Proc Natl Acad Sci USA 1987; 84: 2002.
11. William DP, Parker K, Bacha P, et al. Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Engineering 1987; 1: 493.
12. Bacha P, Williams DP, Waters C, Williams JM, Murphy JR, Strom TB. Interleukin 2 receptor-targeted cytotoxicity: interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein. J Exp Med 1988; 167: 612.
13. Kelley VE, Bacha P, Pankewycz O, Nichols JC, Murphy JR, Strom TB. Interleukin-2 toxin fusion protein abolishes cell mediated immunity in vivo. Proc Natl Acad Sci USA. 1988; 85: 3980.
14. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
15. Zucker DR, Murphy JR. Monoclonal antibody analysis of diphthe ria toxin: I. Localization of epitopes and neutralization of cytotoxicity. Mol Immunol 1984; 21: 785.
16. Murphy JR, Bacha P, Teng M. Determination of Corynebacterium diphtheriae toxigenicity by a colorimetric tissue color assay. J Clin Microbiol 1978; 7: 91.
17. Robb RJ, Munck A, Smith KA. T cell growth factor receptors: quantitation, specificity, and biological relevance. J Exp Med 1981; 154: 1455.
18. Robb RJ, Greene WC, Rusk CM. Low and high affinity cellular receptors for interleukin 2: implications for the level of Tac antigen. J Exp Med 1984; 160: 1126.
19. Lowenthal JW, Zubler RH, Nabholz H, MacDonald HR. Similar ities between interleukin-2 receptor and number on activated B and T lymphocytes. Nature 1985; 315: 669.
20. Holter W, Goldman CK, Casabo L, Nelson DL, Greene WC, Waldmann TA. Expression of functional IL-2 receptors by lipo- polysaccharide and interferon-stimulated human monocytes. J Immunol 1987; 138: 2917.
21. Palacios R, Kiefer M, Brockhaus M, et al. Molecular, cellular and functional properties of bone marrow T lymphocyte progenitor clones. J Exp Med 1987; 166: 12.
22. Bacha P, Murphy JR, Reichlin S. Thyrotropin-releasing hormone- diphtheria toxin-related polypeptide conjugates: potential role of the hydrophobic domain in toxin entry. J Biol Chem 1983; 258: 1565.
23. Lorberboum-Galski H, FitzGerald D, Chaudhary V, Adhya S, Pas- tan I. Cytotoxic activity of an interleukin 2-pseudomonas exotoxin chimeric protein produced in E. coli. Proc Natl Acad Sci USA (in press).